Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.
Category
Research
-
-
Research HighlightsEAN NewsFeatured Slider
Research Highlights of the Month – December 2024
December 10, 2024Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for December 2024. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease
December 10, 2024Our paper of the month highlights the findings of the stage 2 interim analysis from the first cycle of MND SMART, a phase 3, multi-arm, randomised, adaptive platform trial conducted across 20 centres in the UK. -
Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.
-
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Safety and efficacy of evobrutinib in relapsing multiple sclerosis
November 6, 2024Our paper of the month for November presents the findings from two large trials comparing the safety and efficacy of evobrutinib with teriflunomide in adults with a diagnosis of relapsing MS. -
Research HighlightsEAN NewsFeatured Slider
Research Highlights of the Month – November 2024
November 6, 2024Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2024. -
ResearchScientific Corner
Call for Proposals: Integrating Vascular Architecture into EBRAINS Human Brain Atlas
October 8, 2024EBRAINS has announced an open call for proposals aimed at integrating models of the brain's vascular architecture with EBRAIN’s Human Brain Atlas, with the aim of enhancing the usability of brain vasculature data for research and clinical applications, fostering collaboration between institutions and the EBRAINS consortium. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: A Monoclonal Antibody to PACAP for Migraine Prevention
October 7, 2024Our Paper of the Month for October is a phase 2, double-blind, randomised, placebo-controlled trial investigating the efficacy of a monoclonal antibody (Lu AG09222) that inhibits PACAP signalling. -
Paper of the MonthResearch HighlightsEAN NewsFeatured Slider
Research Highlights of the Month – October 2024
October 7, 2024Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for October 2024. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
September 12, 2024Our paper of the month for September updates the 2020 Lancet Commission report on the identification of risk factors for dementia, adding two more risk factors to the list. -
Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for September 2024.
-
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
August 7, 2024Our paper of the month for August is a randomised controlled trial evaluating tenecteplase administered 4.5 to 24 hours after stroke onset in 516 Chinese patients. -
Research HighlightsEAN NewsFeatured Slider
Research Highlights of the Month – August 2024
August 7, 2024Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for August 2024. -
The European Platform for Neurodegenerative Diseases project has launched an open call for expressions of interest to leverage biosamples and datasets catalogued on its platform.
-
Results of a short survey conducted among EAN panel members about their competence, interest, and knowledge of the new connectomics methods for studying clinical conditions